Back to all studies
CompletedNCT00214578

Seroquel on Glucose Metabolism

This study is completed. It focuses on schizophrenia and currently lists study information in Bulgaria, Czech Republic, Germany, Hungary, Norway, Romania, Slovakia, South Africa, and the United Kingdom.

SchizophreniaDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Seroquel (quetiapine) may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Seroquel (quetiapine), attend study visits with the research team. The registry lists locations in Bulgaria, in Czechia, and in Germany.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateApril 2004
Recruitment status
Completed
Enrollment listed in the registry
572
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom, Bulgaria, Czechia, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00214578
Official title
Seroquel on Glucose Metabolism

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00214578. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Bulgaria · 5 sites
  • Research Site
    Burgas
    Site status: Not listed — confirm with the team
  • Research Site
    Rousse
    Site status: Not listed — confirm with the team
  • Research Site
    Sofia
    Site status: Not listed — confirm with the team
  • Research Site
    Sofia- Novi Iskar
    Site status: Not listed — confirm with the team
  • Research Site
    Varna
    Site status: Not listed — confirm with the team
Czechia · 8 sites
  • Research Site
    Dobjany
    Site status: Not listed — confirm with the team
  • Research Site
    Dob¿any U Plzn¿
    Site status: Not listed — confirm with the team
  • Research Site
    Havlí¿k¿v Brod
    Site status: Not listed — confirm with the team
  • Research Site
    Kladno
    Site status: Not listed — confirm with the team
  • Research Site
    Miro¿ov
    Site status: Not listed — confirm with the team
  • Research Site
    Opava
    Site status: Not listed — confirm with the team
  • Research Site
    Pilsen
    Site status: Not listed — confirm with the team
  • Research Site
    Prague
    Site status: Not listed — confirm with the team
Germany · 13 sites
  • Research Site
    Tübingen, Baden-Wurttemberg
    Site status: Not listed — confirm with the team
  • Research Site
    München, Bavaria
    Site status: Not listed — confirm with the team
  • Research Site
    Bonn, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Research Site
    Düsseldorf, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Research Site
    Münster, North Rhine-Westphalia
    Site status: Not listed — confirm with the team
  • Research Site
    Magdeburg, Saxony-Anhalt
    Site status: Not listed — confirm with the team
  • Research Site
    Berlin
    Site status: Not listed — confirm with the team
  • Research Site
    Bonn
    Site status: Not listed — confirm with the team
  • Research Site
    Düsseldorf
    Site status: Not listed — confirm with the team
  • Research Site
    Herten
    Site status: Not listed — confirm with the team
  • Research Site
    Magdeburg
    Site status: Not listed — confirm with the team
  • Research Site
    München
    Site status: Not listed — confirm with the team
  • Research Site
    Tübingen
    Site status: Not listed — confirm with the team
Hungary · 10 sites
  • Research Site
    Balassagyarmat
    Site status: Not listed — confirm with the team
  • Research Site
    Budapest
    Site status: Not listed — confirm with the team
  • Research Site
    Cegléd
    Site status: Not listed — confirm with the team
  • Research Site
    Debrecen
    Site status: Not listed — confirm with the team
  • Research Site
    Eger
    Site status: Not listed — confirm with the team
  • Research Site
    Gy¿r
    Site status: Not listed — confirm with the team
  • Research Site
    Kaposvár
    Site status: Not listed — confirm with the team
  • Research Site
    Kecskemét
    Site status: Not listed — confirm with the team
  • Research Site
    Szeged
    Site status: Not listed — confirm with the team
  • Research Site
    Szolnok
    Site status: Not listed — confirm with the team
Norway · 7 sites
  • Research Site
    Bergen
    Site status: Not listed — confirm with the team
  • Research Site
    Drammen
    Site status: Not listed — confirm with the team
  • Research Site
    Hagavik
    Site status: Not listed — confirm with the team
  • Research Site
    Stavanger
    Site status: Not listed — confirm with the team
  • Research Site
    Stokmarknes
    Site status: Not listed — confirm with the team
  • Research Site
    Straume
    Site status: Not listed — confirm with the team
  • Research Site
    Tønsberg
    Site status: Not listed — confirm with the team
Romania · 3 sites
  • Research Site
    Brasov
    Site status: Not listed — confirm with the team
  • Research Site
    Bucharest
    Site status: Not listed — confirm with the team
  • Research Site
    Iași
    Site status: Not listed — confirm with the team
Slovakia · 12 sites
  • Research Site
    Banská Bystrica
    Site status: Not listed — confirm with the team
  • Research Site
    Bojnice
    Site status: Not listed — confirm with the team
  • Research Site
    Bratislava
    Site status: Not listed — confirm with the team
  • Research Site
    Domaša
    Site status: Not listed — confirm with the team
  • Research Site
    Ko¿ice
    Site status: Not listed — confirm with the team
  • Research Site
    Liptovský Mikulá¿
    Site status: Not listed — confirm with the team
  • Research Site
    Michalovce Strá¿any
    Site status: Not listed — confirm with the team
  • Research Site
    Nitra
    Site status: Not listed — confirm with the team
  • Research Site
    Pre¿ov
    Site status: Not listed — confirm with the team
  • Research Site
    Rimavská Sobota
    Site status: Not listed — confirm with the team
  • Research Site
    ¿ilina-Byt¿ica
    Site status: Not listed — confirm with the team
  • Research Site
    ¿ilina
    Site status: Not listed — confirm with the team
South Africa · 10 sites
  • Research Site
    Medunsa, Pretoria
    Site status: Not listed — confirm with the team
  • Research Site
    Bloemfontein
    Site status: Not listed — confirm with the team
  • Research Site
    CapeTown
    Site status: Not listed — confirm with the team
  • Research Site
    Durban
    Site status: Not listed — confirm with the team
  • Research Site
    Ga-Rankuwa
    Site status: Not listed — confirm with the team
  • Research Site
    Johannesburg
    Site status: Not listed — confirm with the team
  • Research Site
    Krugersdorp
    Site status: Not listed — confirm with the team
  • Research Site
    Parktown
    Site status: Not listed — confirm with the team
  • Research Site
    Pretoria
    Site status: Not listed — confirm with the team
  • Research Site
    Tygerberg
    Site status: Not listed — confirm with the team
United Kingdom · 2 sites
  • Research Site
    Sutton Coldfield, West Midlands
    Site status: Not listed — confirm with the team
  • Research Site
    Birmingham
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Seroquel (quetiapine). Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AstraZeneca, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me